Skip to main content
UniHealth

Doctor search

Charlene Hu, MD

Neurology · Stanford

NPI 1770560013

Medicare standing
Clear
Enrolled, allowed to bill and order, not excluded
Plans that list them
11
3 carriers
Office
1

Offices

1 location · Stanford Health Care · 3,152 clinicians in this group

Looking this up.

Hospitals listed: Stanford Health Care · Stanford Health Care Tri-Valley. That is not proof they admit you there this week.

Plans that list them

11 plans · 3 carriers

A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Hu’s office at (650) 723-4000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.

11 of 11 plans

Plans whose provider directory lists this clinician
Alignment Health BreathEasy (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Clarity (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Harmony (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes CalPlus (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes Care (HMO C-SNP)Alignment Health PlanListedSep 28, 2026
Alignment Health Heart & Diabetes Choice (HMO C-SNP)Alignment Health PlanListedSep 28, 2026
Alignment Health Honor+ Plan (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health My Choice CalCare (HMO)Alignment Health PlanListedOct 3, 2026
Anthem Full Dual Advantage Aligned (HMO D-SNP)Anthem Blue CrossListedOct 3, 2026
SCAN Strive (HMO C-SNP)SCAN Health PlanListedOct 3, 2026

California Medical Board record

Licence A79330 · Current

Licensed to practise in California · since 2002 · expires 2028-05-31 · Chekiang Medical University Aka Zhejiang Medical University.

No disciplinary actions, convictions, malpractice judgments or citations in this record.

Hospitals they work in

2 hospitals

These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.

  • Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend it
    Overall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
  • Stanford Health Care Tri-ValleyPleasanton, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Stanford Health Care, which runs 3 hospitalsPatients rate it 3 of 5 · 74% would definitely recommend it
    Overall rating: 5 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.178, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.237, Oct 2024 – Sep 2025
See every measure and the patient survey for Stanford Health Care

Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at Stanford Health Care
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths5.31 (4.24 to 6.37) · 8,661 casesWorseJul 2022 – Jun 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits14.1 (12.7 to 15.7) · 2,191 casesWorseJan 2024 – Dec 2024
Postoperative respiratory failure rateComplications and deaths4.08 (1.95 to 6.21) · 5,296 casesBetterJul 2022 – Jun 2024
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.317BetterOct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections0.446BetterOct 2024 – Sep 2025
SSI - Colon SurgeryInfections0.241BetterOct 2024 – Sep 2025
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits0.7 (0.6 to 0.9) · 3,348 casesBetterJan 2024 – Dec 2024
Abdominopelvic accidental puncture or laceration rateComplications and deaths1.06 (0.45 to 1.67) · 5,374 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths0.86 (0.72 to 1)No differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths166.09 (137.88 to 194.3) · 470 casesNo differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths1.1 · 192 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths6.4 · 146 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths9.7 · 253 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths6.3 · 880 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths10.3 · 935 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths8.7 · 501 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths2.1 · 7,730 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.13 (0 to 0.27) · 20,799 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.28 (0.14 to 0.43) · 23,182 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths0.94 (0.2 to 1.68) · 5,694 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths2.36 (1.54 to 3.19) · 7,846 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths5.2 (3.76 to 6.64) · 5,603 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.38 (0.23 to 2.53) · 2,211 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.52 (0.21 to 0.83) · 19,915 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths3.6 · 416 casesNoneApr 2023 – Mar 2025
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.869No differentOct 2024 – Sep 2025
MRSA BacteremiaInfections0.857No differentOct 2024 – Sep 2025
SSI - Abdominal HysterectomyInfections0.368No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits16.2 · 247 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits20.5 · 1,021 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits47.8 · 258 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits-1.6 · 990 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits20.8 · 976 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits16.5 · 959 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits5.2 (4.4 to 6.2) · 2,191 casesNo differentJan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits5.1 · 425 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits9.6 · 158 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits19.6 · 183 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits12.7 (10.4 to 15.4) · 4,578 casesNo differentJan 2022 – Dec 2024

What patients said (6,810 patients answered, 25% of those asked)

Patient survey stars by topic at Stanford Health Care
Cleanliness4
Nurse communication4
Doctor communication4
Communication about medicines3
Discharge information4
Overall hospital rating4
Quietness2
Recommend hospital5
Share of patients giving the best answer at Stanford Health Care
Room was "always" clean75%
Nurses "always" communicated well82%
Doctors "always" communicated well81%
Staff "always" explained63%
Yes, staff "did" give patients this information89%
Yes, staff "did" give patients information about help after discharge89%
Doctors "always" explained things so they could understand76%
Doctors "always" listened carefully80%
Doctors "always" treated them with courtesy and respect87%
Patients who gave a rating of "9" or "10" (high)79%
Staff "always" explained new medications76%
Nurses "always" explained things so they could understand77%
Nurses "always" listened carefully79%
Nurses "always" treated them with courtesy and respect88%
"Always" quiet at night53%
"YES", patients would definitely recommend the hospital83%
Staff "always" explained possible side effects50%
Yes, staff "did" give patients information about possible symptoms90%
See every measure and the patient survey for Stanford Health Care Tri-Valley

Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 2 better, 7 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at Stanford Health Care Tri-Valley
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.178BetterOct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections0.237BetterOct 2024 – Sep 2025
Abdominopelvic accidental puncture or laceration rateComplications and deaths0.79 (0 to 1.73) · 1,041 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths0.79 (0.5 to 1.08)No differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths145.81 (96.5 to 195.12) · 72 casesNo differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths2.9 · 55 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths8.6 · 92 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths12.5 · 96 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths9.5 · 395 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths10.3 · 391 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths10.1 · 162 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths3 · 1,736 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.16 (0 to 0.37) · 4,425 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.22 (0.02 to 0.41) · 4,771 casesNo differentJul 2022 – Jun 2024
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths3.45 (1.46 to 5.44) · 1,403 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths1.5 (0.05 to 2.94) · 645 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths1.81 (0.38 to 3.24) · 1,279 casesNo differentJul 2022 – Jun 2024
Postoperative respiratory failure rateComplications and deaths8.53 (3.2 to 13.85) · 639 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths5.15 (1.89 to 8.41) · 648 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.61 (0.14 to 3.07) · 370 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.16 (0 to 0.83) · 4,160 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths4 · 74 casesNoneApr 2023 – Mar 2025
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.369No differentOct 2024 – Sep 2025
MRSA BacteremiaInfections1.112No differentOct 2024 – Sep 2025
SSI - Colon SurgeryInfections0No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits13.1 · 110 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits20.1 · 437 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits-5.8 · 94 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits-19.3 · 456 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits-0.3 · 402 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits15.8 · 358 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits6.8 (4.7 to 9.6) · 198 casesNo differentJan 2024 – Dec 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits10.1 (7.5 to 13.6) · 198 casesNo differentJan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits5.3 · 80 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits10.9 · 46 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits19.3 · 92 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits12.4 (9.6 to 16.2) · 1,532 casesNo differentJan 2022 – Dec 2024
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits1 (0.8 to 1.2) · 929 casesNo differentJan 2024 – Dec 2024

What patients said (1,268 patients answered, 26% of those asked)

Patient survey stars by topic at Stanford Health Care Tri-Valley
Cleanliness3
Nurse communication3
Doctor communication4
Communication about medicines3
Discharge information4
Overall hospital rating3
Quietness2
Recommend hospital4
Share of patients giving the best answer at Stanford Health Care Tri-Valley
Room was "always" clean65%
Nurses "always" communicated well77%
Doctors "always" communicated well79%
Staff "always" explained58%
Yes, staff "did" give patients this information88%
Yes, staff "did" give patients information about help after discharge88%
Doctors "always" explained things so they could understand74%
Doctors "always" listened carefully78%
Doctors "always" treated them with courtesy and respect86%
Patients who gave a rating of "9" or "10" (high)70%
Staff "always" explained new medications72%
Nurses "always" explained things so they could understand73%
Nurses "always" listened carefully74%
Nurses "always" treated them with courtesy and respect84%
"Always" quiet at night42%
"YES", patients would definitely recommend the hospital74%
Staff "always" explained possible side effects44%
Yes, staff "did" give patients information about possible symptoms89%

Original Medicare doctor bills

$232,783

Medicare paid this office $232,783 for 677 people.

This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.

Largest Original Medicare bills
Return visit (30+ min)391$75,180$111
Botox21$42,713None
Long return visit (40+ min)150$31,650$154
New patient visit (45+ min)179$26,112$146
Short return visit (20+ min)220$22,876$77
See all 13 services
Every Original Medicare service billed
Return visit (30+ min)391$75,180$111
Botox21$42,713None
Long return visit (40+ min)150$31,650$154
New patient visit (45+ min)179$26,112$146
Short return visit (20+ min)220$22,876$77
New patient visit (60+ min)42$8,210$195
Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face21$7,641$127
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's242$4,925$15
Measurement of brain wave activity (eeg), awake and asleep25$4,502$150
Nerve test18$2,246$125
Muscle electrical test27$1,801$62
New patient visit (30+ min)13$1,380$106
Telephone, internet, or electronic health record assessment and management with written report by consulting physician, at least 5 minutes20$560$28

Who their Medicare patients are

677 Original Medicare patients in 2024. Average age 78 · Under 65 6% · 85 and older 23% · Women 62% · Also on Medicaid 18% · Health risk score 1.47. At or below the middle of the specialty; the typical neurology clinician is at 1.61.

Conditions among them: High blood pressure 75% · Chronic kidney disease 34% · Dementia 34% · Diabetes 31% · Depression 30% · Coronary heart disease 28% · Stroke 22% · Atrial fibrillation 20% · Cancer 18% · Heart failure 16% · COPD 15%.

The office billed $1,217,912, Medicare allowed $312,923 and paid $232,783; for 10,645 services of 19 kinds; $42,713 of it was for drugs given in the office and $190,070 for care.

Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.

Year by year

Original Medicare by year
202467710,645781.47$1,217,912$232,783
20237337,072771.56$917,320$213,852
20227957,274771.51$963,951$216,100
20217357,598771.45$1,002,447$240,024
20206616,206771.66$988,096$202,842
20196655,592761.51$1,034,867$220,905
20186116,788771.70$936,584$221,760
20175926,331761.58$809,822$200,949
20166658,142761.74$920,227$229,985
20156076,588761.74$732,697$214,329
20145294,801761.62$501,731$176,445
20134734,452751.63$415,358$175,696

Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.

See the services billed each year

2023: 16 services

Original Medicare services billed in 2023
Return visit (30+ min)372$63,656$108
Long return visit (40+ min)224$45,143$155
Botox13$25,624None
Short return visit (20+ min)211$21,541$75
New patient visit (45+ min)128$17,375$136
New patient visit (60+ min)66$12,447$189
Initial hospital care with moderate level of medical decision making at least 75 minutes37$5,542$150
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes26$5,168$105
Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face16$4,717$131
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes27$2,527$70
Measurement of brain wave activity (eeg), awake and asleep36$1,987$50
Muscle electrical test13$1,526$69
New patient visit (30+ min)18$1,365$76
Telehealth originating site facility fee51$1,196$22
Measurement of brain wave activity (eeg), awake and asleep15$814$51
Telephone, internet, or electronic health record assessment and management with written report by consulting physician, at least 5 minutes16$415$26

2022: 14 services

Original Medicare services billed in 2022
Return visit (30+ min)390$61,850$104
Long return visit (40+ min)204$43,917$153
Botox11$26,086None
New patient visit (45+ min)195$25,195$129
Short return visit (20+ min)190$17,009$72
New patient visit (60+ min)77$14,918$194
Initial hospital care with moderate level of medical decision making at least 75 minutes37$6,344$171
Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face11$3,802$136
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes26$3,522$88
Measurement of brain wave activity (eeg), awake and asleep58$3,074$49
New patient visit (30+ min)28$2,608$93
Muscle electrical test12$1,629$102
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes20$1,246$62
Telephone, internet, or electronic health record assessment and management with written report by consulting physician, at least 5 minutes13$352$27

2021: 14 services

Original Medicare services billed in 2021
Return visit (30+ min)363$70,505$111
Long return visit (40+ min)187$43,850$164
New patient visit (45+ min)210$29,644$141
Botox11$27,248None
New patient visit (60+ min)79$15,749$199
Short return visit (20+ min)130$12,508$76
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes44$8,717$93
Initial hospital care with moderate level of medical decision making at least 75 minutes38$7,085$182
Telephone medical discussion with physician, 21-30 minutes35$3,125$87
Measurement of brain wave activity (eeg), awake and asleep51$3,070$53
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes27$2,868$64
New patient visit (30+ min)29$2,588$89
Muscle electrical test12$1,836$97
Administration of influenza virus vaccine11$234$21

2020: 19 services

Original Medicare services billed in 2020
Return visit (30+ min)339$52,780$91
New patient visit (45+ min)180$25,626$142
Long return visit (40+ min)142$23,915$127
New patient visit (60+ min)63$11,907$189
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes53$10,720$96
Initial hospital care with moderate level of medical decision making at least 75 minutes55$9,691$170
Short return visit (20+ min)107$7,702$60
Telephone medical discussion with physician, 21-30 minutes46$5,931$104
Muscle electrical test31$4,280$93
Measurement of brain wave activity (eeg), awake and asleep67$4,143$54
Nerve test16$3,070$192
Extended office or other outpatient service, first hour20$2,907$121
Telephone medical discussion with physician, 11-20 minutes34$2,675$70
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes24$2,207$67
Nerve test12$1,592$122
New patient visit (30+ min)15$1,448$97
Influenza vaccine split virus, preservative free19$1,159$61
Extended inpatient or observation hospital service, first hour11$1,022$85
Administration of influenza virus vaccine19$391$21

2019: 17 services

Original Medicare services billed in 2019
Return visit (30+ min)368$66,652$93
Long return visit (40+ min)182$35,676$130
New patient visit (45+ min)206$29,481$143
New patient visit (60+ min)66$12,046$183
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes48$8,674$91
Muscle electrical test56$8,443$91
Short return visit (20+ min)106$7,060$61
Initial hospital care with moderate level of medical decision making at least 75 minutes35$6,322$176
Nerve test19$4,051$193
Measurement of brain wave activity (eeg), awake and asleep58$3,538$53
Nerve test23$3,378$147
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes27$3,213$66
New patient visit (30+ min)25$2,415$97
Extended office or other outpatient service, first hour17$2,262$119
Nerve test12$1,464$122
Follow-up observation care per day, typically 35 minutes12$1,421$95
Extended inpatient or observation hospital service, first hour11$924$84

2018: 16 services

Original Medicare services billed in 2018
Return visit (30+ min)354$71,193$93
New patient visit (45+ min)171$24,087$141
Long return visit (40+ min)102$18,444$130
Initial hospital care with moderate level of medical decision making at least 75 minutes77$15,051$175
New patient visit (60+ min)64$11,781$184
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes62$7,632$65
Short return visit (20+ min)96$6,830$57
Muscle electrical test51$6,622$86
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes35$6,485$93
Measurement of brain wave activity (eeg), awake and asleep23$6,442$239
Nerve test23$4,604$192
Extended office or other outpatient service, first hour24$2,937$117
Nerve test18$2,356$124
Measurement of brain wave activity (eeg), awake and asleep32$2,049$53
New patient visit (30+ min)19$1,904$100
Nerve test12$1,774$148

2017: 17 services

Original Medicare services billed in 2017
Return visit (30+ min)364$73,786$92
New patient visit (45+ min)185$25,798$139
Initial hospital care with moderate level of medical decision making at least 75 minutes89$16,644$177
Short return visit (20+ min)164$13,244$62
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes82$12,144$63
Long return visit (40+ min)41$6,467$127
Muscle electrical test58$6,288$74
Nerve test21$3,766$179
New patient visit (60+ min)18$3,166$176
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes19$2,739$91
Nerve test23$2,647$115
Initial hospital observation care per day, typically 70 minutes14$2,441$163
Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes38$2,388$34
Measurement of brain wave activity (eeg), awake and asleep24$1,397$52
Nerve test15$1,262$84
Follow-up observation care per day, typically 25 minutes13$960$64
Measurement of brain wave activity (eeg), awake and asleep15$828$52

2016: 18 services

Original Medicare services billed in 2016
Return visit (30+ min)366$68,246$91
New patient visit (45+ min)219$30,234$138
Botox11$26,578None
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes123$24,738$62
Initial hospital care with moderate level of medical decision making at least 75 minutes123$23,419$172
Short return visit (20+ min)168$12,849$61
Initial hospital observation care per day, typically 70 minutes40$6,533$159
Long return visit (40+ min)33$4,955$124
Muscle electrical test59$4,672$52
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes28$4,555$89
Nerve test29$3,245$112
New patient visit (60+ min)17$3,050$179
Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes49$3,029$34
Nerve test18$1,653$92
Measurement of brain wave activity (eeg), awake and asleep26$1,540$50
Follow-up observation care per day, typically 25 minutes21$1,505$63
Nerve test17$1,307$77
Measurement of brain wave activity (eeg), awake and asleep11$658$51

2015: 17 services

Original Medicare services billed in 2015
Return visit (30+ min)275$55,205$92
Initial hospital care with moderate level of medical decision making at least 75 minutes154$30,189$175
New patient visit (45+ min)178$24,567$138
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes136$23,093$62
Short return visit (20+ min)180$15,789$62
Initial hospital observation care per day, typically 70 minutes44$7,181$160
Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes79$4,934$34
Nerve test31$4,787$150
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes27$4,308$90
Muscle electrical test58$4,082$44
Nerve test19$2,213$116
Follow-up observation care per day, typically 25 minutes24$2,197$63
New patient visit (30+ min)26$2,192$84
Long return visit (40+ min)13$1,682$129
Measurement of brain wave activity (eeg), awake and asleep23$1,264$51
Short return visit14$559$40
Follow-up observation care per day, typically 15 minutes12$474$34

2014: 16 services

Original Medicare services billed in 2014
Return visit (30+ min)245$44,359$91
Initial hospital care with moderate level of medical decision making at least 75 minutes155$29,026$174
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes153$24,199$62
New patient visit (45+ min)116$15,779$136
Short return visit (20+ min)149$12,430$61
Initial hospital observation care per day, typically 70 minutes32$5,085$159
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes29$4,089$89
Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes62$3,959$34
Nerve test21$3,218$153
Follow-up observation care per day, typically 25 minutes36$3,186$62
Muscle electrical test46$3,114$40
New patient visit (30+ min)31$2,773$89
Long return visit (40+ min)20$2,536$127
Nerve test17$2,087$123
Measurement of brain wave activity (eeg), awake and asleep26$1,511$50
Return visit (30+ min)13$946$68

2013: 13 services

Original Medicare services billed in 2013
Initial hospital care with moderate level of medical decision making at least 75 minutes178$32,923$167
Return visit (30+ min)185$31,303$88
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes154$24,136$60
Measurement of brain wave activity (eeg), awake and asleep30$17,435$447
New patient visit (45+ min)121$17,296$143
Short return visit (20+ min)168$15,230$59
Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes76$4,024$33
Muscle electrical test37$3,928$79
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes20$2,878$87
Nerve test12$2,035$170
Long return visit (40+ min)12$1,655$127
Nerve test11$1,175$107
Measurement of brain wave activity (eeg), awake and asleep19$948$45

Drugs they prescribed that Part D paid

$381,240

Pharmacies billed $381,240 in 2024.

This is pharmacy cost, not the office bill, and not what patients paid.

Opioids were 0% of their Part D prescriptions (0 of 2,749) in 2024. At or below the middle of the specialty; the typical neurology clinician is at 0%.

2,626 generic and fewer than 11 brand-name prescriptions · $381,240 in drug cost · 80 antipsychotic prescriptions to people over 65.

Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.

Largest Part D drug costs
TecfideraNone11$97,006$8,819
AimovigMigraine23$30,692$1,334
Nurtec OdtNone16$27,345$1,709
NamzaricNone21$24,909$1,186
AjovyNone17$12,026$707
See all 40 drugs
Every Part D drug this clinician prescribed
TecfideraNone11$97,006$8,819
AimovigMigraine23$30,692$1,334
Nurtec OdtNone16$27,345$1,709
NamzaricNone21$24,909$1,186
AjovyNone17$12,026$707
MemantineNone217$8,503$39
DonepezilNone539$7,970$15
LevetiracetamNone182$5,903$32
RivastigmineNone17$5,484$323
Memantine Hcl ErNone34$4,503$132
Carbidopa-LevodopaNone145$4,155$29
GabapentinNone131$2,981$23
RivastigmineNone32$2,907$91
OxcarbazepineNone39$2,513$64
PregabalinNone42$2,419$58
TopiramateNone111$2,368$21
RizatriptanNone67$2,276$34
NortriptylineNone94$1,730$18
Carbidopa-Levodopa ErNone28$1,542$55
LamotrigineNone41$1,480$36
PrimidoneNone77$1,299$17
MirtazapineNone45$1,290$29
RopiniroleNone46$1,142$25
BaclofenNone18$1,021$57
QuetiapineNone62$983$16
EscitalopramNone68$939$14
Pramipexole DihydrochlorideNone50$817$16
ClopidogrelNone34$767$23
AmantadineNone25$744$30
SertralineNone60$724$12
AtorvastatinNone66$685$10
EntacaponeNone12$655$55
DivalproexNone13$587$45
Eletriptan HbrNone13$566$44
Venlafaxine Hcl ErNone28$456$16
SumatriptanNone17$372$22
Valproic AcidNone12$309$26
LorazepamNone89$290$3
PropranololNone15$271$18
TizanidineNone15$111$7

Year by year

Part D prescribing by year
20242,7495700% (0)None$381,240
20232,799526None4%$510,823
20222,929525NoneNone$602,631
20212,8594951% (23)4%$389,005
20202,5644501% (13)6%$393,153
20192,449402None8%$392,594
20182,1953461% (22)None$342,905
20172,3843041% (18)None$396,405
20162,3613232% (35)None$388,319
20151,8302732% (35)None$299,816
20141,3802062% (26)None$264,350
20131,2731802% (26)30%$239,969

Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.

See the drugs prescribed each year

2023: 37 drugs

Part D drugs prescribed in 2023
CopaxoneNone12$86,238$7,187
AimovigMigraine24$39,560$1,648
NamzaricNone18$25,637$1,424
DonepezilNone527$14,518$28
MemantineNone235$14,431$61
LacosamideNone12$13,001$1,083
LevetiracetamNone191$9,864$52
Carbidopa-LevodopaNone182$7,294$40
RivastigmineNone18$5,908$328
Memantine Hcl ErNone22$5,443$247
RivastigmineNone35$4,475$128
NortriptylineNone119$3,983$33
TopiramateNone110$3,826$35
GabapentinNone139$3,234$23
PrimidoneNone88$2,697$31
OxcarbazepineNone33$2,666$81
RizatriptanNone54$2,499$46
QuetiapineNone53$2,195$41
RopiniroleNone56$1,905$34
EscitalopramNone96$1,904$20
DivalproexNone46$1,811$39
AtorvastatinNone66$1,759$27
BaclofenNone13$1,561$120
LamotrigineNone34$1,428$42
PregabalinNone22$1,212$55
MidodrineNone12$1,168$97
Pramipexole DihydrochlorideNone36$1,114$31
PhenobarbitalNone12$1,055$88
MirtazapineNone42$973$23
ClopidogrelNone41$965$24
OlanzapineNone13$739$57
SumatriptanNone22$651$30
SertralineNone59$584$10
LorazepamNone76$381$5
Venlafaxine Hcl ErNone11$302$27
PropranololNone13$261$20
TrazodoneNone14$30$2

2022: 43 drugs

Part D drugs prescribed in 2022
CopaxoneNone18$145,551$8,086
TecfideraNone12$113,709$9,476
NeuproNone17$35,888$2,111
AimovigMigraine26$34,498$1,327
NamzaricNone32$30,542$954
RivastigmineNone31$12,938$417
MemantineNone215$12,255$57
CarbidopaNone13$11,107$854
VimpatNone11$10,612$965
Carbidopa-LevodopaNone249$8,369$34
DonepezilNone498$8,323$17
LevetiracetamNone162$6,885$43
QuetiapineNone52$6,027$116
Memantine Hcl ErNone18$4,756$264
TopiramateNone129$4,011$31
GabapentinNone123$3,377$27
NortriptylineNone133$3,321$25
DivalproexNone75$2,965$40
EscitalopramNone151$2,446$16
RopiniroleNone78$2,242$29
RizatriptanNone51$2,216$43
DuloxetineNone18$2,168$120
Carbidopa-Levodopa ErNone13$2,168$167
BaclofenNone13$1,891$145
OxcarbazepineNone35$1,773$51
RivastigmineNone15$1,672$111
Divalproex Sodium ErNone12$1,592$133
AmantadineNone14$1,374$98
PyridostigmineNone11$1,362$124
PrimidoneNone79$1,361$17
Pramipexole DihydrochlorideNone41$1,171$29
AtorvastatinNone55$958$17
LamotrigineNone34$946$28
MirtazapineNone46$848$18
ClopidogrelNone41$833$20
SertralineNone68$730$11
PropranololNone13$696$54
PregabalinNone16$425$27
LorazepamNone95$325$3
Venlafaxine Hcl ErNone13$250$19
FluoxetineNone16$239$15
DiazepamNone11$201$18
SumatriptanNone14$190$14

2021: 43 drugs

Part D drugs prescribed in 2021
TecfideraNone13$114,264$8,790
NamzaricNone29$30,267$1,044
NeuproNone14$30,197$2,157
AimovigMigraine16$15,600$975
CarbidopaNone12$12,932$1,078
MemantineNone164$11,892$73
RivastigmineNone27$11,242$416
Carbidopa-LevodopaNone215$9,660$45
Memantine Hcl ErNone33$8,871$269
DonepezilNone455$7,956$17
LevetiracetamNone169$6,684$40
TopiramateNone148$3,957$27
RivastigmineNone37$3,047$82
OxcarbazepineNone30$2,679$89
GabapentinNone117$2,317$20
RopiniroleNone67$2,278$34
Pramipexole DihydrochlorideNone66$2,232$34
PregabalinNone29$1,919$66
Divalproex Sodium ErNone17$1,889$111
Carbidopa-Levodopa ErNone18$1,875$104
AmantadineNone15$1,615$108
PhenobarbitalNone17$1,578$93
DuloxetineNone15$1,476$98
BaclofenNone11$1,296$118
AtorvastatinNone69$1,291$19
MirtazapineNone56$1,282$23
NortriptylineNone111$1,266$11
EscitalopramNone93$1,216$13
LamotrigineNone49$1,144$23
PyridostigmineNone43$1,085$25
SertralineNone88$947$11
RizatriptanNone14$844$60
PropranololNone15$821$55
PrimidoneNone68$794$12
ClopidogrelNone46$652$14
DivalproexNone25$559$22
QuetiapineNone44$527$12
LorazepamNone105$497$5
FluoxetineNone14$412$29
Venlafaxine Hcl ErNone16$259$16
SumatriptanNone28$233$8
DiazepamNone13$162$12
TramadolNone13$17$1

2020: 47 drugs

Part D drugs prescribed in 2020
Namzaric38$34,047$896
Neupro27$32,638$1,209
Trokendi Xr15$16,629$1,109
Carbidopa12$13,429$1,119
Memantine Hcl Er51$12,407$243
Carbidopa-Levodopa218$9,609$44
Memantine134$9,063$68
Rasagiline Mesylate11$8,624$784
Ajovy12$8,430$702
Donepezil411$7,371$18
Rivastigmine12$6,070$506
Levetiracetam158$6,016$38
Oxcarbazepine35$3,829$109
Topiramate149$3,810$26
Rivastigmine36$2,895$80
Gabapentin107$2,487$23
Amantadine23$2,245$98
Baclofen14$2,240$160
Carbidopa-Levodopa Er11$2,216$201
Ropinirole58$1,912$33
Eletriptan Hbr13$1,613$124
Mirtazapine55$1,601$29
Divalproex Sodium Er13$1,570$121
Pyridostigmine20$1,458$73
Phenobarbital17$1,445$85
Pregabalin20$1,364$68
Fluoxetine21$1,159$55
Sertraline83$1,104$13
Lamotrigine39$1,095$28
Duloxetine16$1,026$64
Quetiapine49$880$18
Nortriptyline48$850$18
Pramipexole Dihydrochloride54$849$16
Atorvastatin40$700$18
Clopidogrel37$647$17
Primidone38$641$17
Venlafaxine Hcl Er30$638$21
Rizatriptan14$539$39
Propranolol11$465$42
Sumatriptan18$461$26
Escitalopram57$443$8
Divalproex27$301$11
Clonazepam21$227$11
Diazepam11$204$19
Lorazepam82$188$2
Citalopram Hbr27$176$7
Butalbital-Acetaminophen-Caffe17$85$5

2019: 39 drugs

Part D drugs prescribed in 2019
NeuproNone31$38,320$1,236
NamzaricNone46$37,917$824
LyricaNone35$20,901$597
Memantine Hcl ErNone61$18,301$300
MemantineNone147$12,358$84
RivastigmineNone24$8,931$372
AimovigMigraine11$6,763$615
Carbidopa-LevodopaNone228$6,613$29
DonepezilNone343$5,950$17
LevetiracetamNone128$4,596$36
RivastigmineNone45$3,545$79
GabapentinNone99$3,374$34
OxcarbazepineNone39$3,248$83
TopiramateNone117$2,182$19
EscitalopramNone89$1,728$19
EntacaponeNone12$1,586$132
AmantadineNone26$1,524$59
DuloxetineNone23$1,521$66
RopiniroleNone37$1,372$37
MirtazapineNone62$1,372$22
PhenobarbitalNone13$1,206$93
PregabalinNone11$1,059$96
RizatriptanNone19$723$38
SertralineNone91$710$8
LamotrigineNone31$671$22
SumatriptanNone28$666$24
PrimidoneNone45$623$14
Venlafaxine Hcl ErNone33$568$17
Pramipexole DihydrochlorideNone41$542$13
NortriptylineNone32$414$13
QuetiapineNone28$363$13
ClopidogrelNone22$329$15
PropranololNone21$291$14
OlanzapineNone17$190$11
LorazepamNone62$189$3
ClonazepamNone20$166$8
FluoxetineNone21$160$8
AtorvastatinNone12$143$12
Citalopram HbrNone18$79$4

2018: 40 drugs

Part D drugs prescribed in 2018
Neupro31$36,276$1,170
Lyrica49$34,645$707
Namzaric34$26,149$769
Memantine Hcl Er56$23,987$428
Namenda Xr38$23,300$613
Carbidopa12$11,445$954
Rivastigmine33$10,737$325
Memantine117$8,896$76
Carbidopa-Levodopa199$5,477$28
Donepezil282$4,389$16
Levetiracetam127$4,120$32
Propranolol Hcl Er15$2,396$160
Oxcarbazepine33$2,078$63
Pyridostigmine19$1,953$103
Escitalopram87$1,680$19
Topiramate72$1,629$23
Rivastigmine14$1,485$106
Dilantin12$1,338$111
Sertraline133$1,193$9
Gabapentin66$1,107$17
Mirtazapine59$897$15
Primidone62$888$14
Pramipexole Dihydrochloride43$813$19
Ropinirole30$790$26
Venlafaxine Hcl Er32$586$18
Rizatriptan17$583$34
Nortriptyline32$526$16
Clopidogrel26$417$16
Lorazepam68$400$6
Lamotrigine22$399$18
Clonazepam25$336$13
Quetiapine19$284$15
Sumatriptan18$228$13
Atorvastatin16$223$14
Olanzapine21$181$9
Butalbital-Acetaminophen-Caffe11$171$16
Simvastatin19$101$5
Fluoxetine11$97$9
Citalopram Hbr20$61$3
Propranolol16$39$2

2017: 43 drugs

Part D drugs prescribed in 2017
Namenda Xr200$99,322$497
Neupro32$32,479$1,015
Namzaric67$32,267$482
Rasagiline Mesylate38$23,248$612
Lyrica44$20,338$462
Carbidopa12$11,810$984
Vimpat12$9,783$815
Rivastigmine21$7,414$353
Aspirin-Dipyridamole Er11$6,858$623
Donepezil387$4,241$11
Memantine62$3,857$62
Rivastigmine27$3,832$142
Levetiracetam154$3,463$22
Carbidopa-Levodopa170$3,455$20
Entacapone12$3,394$283
Amantadine25$2,740$110
Pyridostigmine16$2,157$135
Oxcarbazepine37$1,856$50
Carbidopa-Levodopa-Entacapone15$1,836$122
Pramipexole Dihydrochloride69$1,171$17
Escitalopram94$1,096$12
Dilantin11$1,094$99
Primidone80$1,045$13
Rizatriptan26$963$37
Ropinirole39$949$24
Topiramate32$772$24
Sertraline57$594$10
Venlafaxine Hcl Er36$566$16
Clopidogrel42$563$13
Gabapentin46$543$12
Fluoxetine19$437$23
Baclofen20$381$19
Mirtazapine29$342$12
Nortriptyline25$315$13
Butalbital-Acetaminophen-Caffe15$272$18
Lorazepam92$257$3
Lamotrigine18$225$13
Quetiapine23$197$9
Atorvastatin19$192$10
Simvastatin16$112$7
Clonazepam30$91$3
Olanzapine12$77$6
Citalopram Hbr17$47$3

2016: 39 drugs

Part D drugs prescribed in 2016
Namenda Xr207$91,851$444
Azilect48$39,932$832
Neupro38$30,542$804
Lyrica40$18,681$467
Exelon20$13,891$695
Rivastigmine40$12,898$322
Aspirin-Dipyridamole Er16$11,320$707
Carbidopa13$7,748$596
Donepezil466$5,126$11
Rivastigmine49$4,578$93
Levetiracetam158$4,256$27
Carbidopa-Levodopa-Entacapone25$3,440$138
Pristiq11$3,173$288
Oxcarbazepine51$3,120$61
Memantine45$3,098$69
Carbidopa-Levodopa131$2,568$20
Pramipexole Dihydrochloride66$2,202$33
Amantadine15$2,044$136
Rizatriptan25$1,742$70
Gabapentin97$1,244$13
Primidone55$1,227$22
Fluoxetine24$1,145$48
Escitalopram62$1,037$17
Ropinirole32$869$27
Clopidogrel32$558$17
Lamotrigine16$462$29
Nortriptyline35$449$13
Topiramate22$429$19
Lorazepam94$394$4
Hydrocodone-Ibuprofen12$375$31
Mirtazapine20$351$18
Quetiapine44$334$8
Venlafaxine Hcl Er13$332$26
Simvastatin17$254$15
Atorvastatin21$218$10
Clonazepam40$210$5
Paroxetine23$172$7
Sertraline32$147$5
Citalopram Hbr15$42$3

2015: 40 drugs

Part D drugs prescribed in 2015
Rebif12$66,591$5,549
Namenda Xr127$52,773$416
Azilect31$29,090$938
Neupro38$25,917$682
Exelon36$21,702$603
Lyrica22$12,394$563
Zomig11$8,079$734
Namenda14$4,988$356
Ropinirole Er16$4,078$255
Donepezil295$3,618$12
Carbidopa-Levodopa143$3,385$24
Pristiq Er13$3,205$247
Levetiracetam88$2,413$27
Amantadine18$1,940$108
Pramipexole Dihydrochloride36$1,892$53
Galantamine Hbr12$1,716$143
Gabapentin95$1,536$16
Oxcarbazepine39$1,535$39
Rivastigmine15$1,103$74
Carbidopa-Levodopa Er13$1,017$78
Memantine12$996$83
Mirtazapine55$620$11
Nortriptyline48$611$13
Primidone29$556$19
Escitalopram26$526$20
Venlafaxine Hcl Er28$495$18
Topiramate47$447$10
Ropinirole26$369$14
Hydrocodone-Ibuprofen12$357$30
Clopidogrel25$314$13
Sertraline49$253$5
Atorvastatin19$241$13
Quetiapine22$234$11
Paroxetine29$232$8
Lorazepam50$203$4
Simvastatin22$198$9
Clonazepam33$183$6
Hydrocodone-Acetaminophen12$138$11
Sumatriptan11$135$12
Citalopram Hbr15$92$6

2014: 36 drugs

Part D drugs prescribed in 2014
Rebif13$65,265$5,020
Azilect29$30,381$1,048
Namenda70$28,253$404
Exelon56$25,873$462
Neupro40$24,407$610
Namenda Xr65$21,606$332
Lyrica40$14,933$373
Zomig12$7,249$604
Donepezil162$5,171$32
Ropinirole35$4,115$118
Pristiq Er11$2,327$212
Gabapentin89$1,893$21
Levetiracetam71$1,889$27
Pramipexole Dihydrochloride25$1,791$72
Oxcarbazepine38$1,718$45
Carbidopa-Levodopa69$1,706$25
Amantadine15$1,344$90
Carbidopa-Levodopa Er18$1,253$70
Dantrolene12$620$52
Topiramate30$565$19
Escitalopram17$467$27
Clopidogrel22$439$20
Venlafaxine Hcl Er11$341$31
Primidone24$337$14
Nortriptyline30$307$10
Mirtazapine22$302$14
Simvastatin26$293$11
Atorvastatin27$277$10
Clonazepam40$205$5
Sumatriptan11$195$18
Lorazepam27$177$7
Sertraline17$139$8
Paroxetine16$116$7
Lamotrigine13$110$8
Hydrocodone-Acetaminophen11$104$9
Fluoxetine12$54$4

2013: 34 drugs

Part D drugs prescribed in 2013
Rebif13$56,774$4,367
Namenda113$39,587$350
Exelon77$30,446$395
Azilect34$28,755$846
Lyrica38$10,409$274
Neupro26$9,394$361
Aricept23$9,350$407
Ropinirole21$3,493$166
Rivastigmine13$3,189$245
Donepezil114$2,847$25
Pramipexole Dihydrochloride38$1,843$49
Levetiracetam63$1,822$29
Carbidopa-Levodopa58$1,656$29
Topiramate43$1,561$36
Gabapentin46$1,287$28
Oxcarbazepine24$1,024$43
Amantadine12$1,023$85
Venlafaxine Hcl Er13$634$49
Dantrolene11$572$52
Divalproex13$356$27
Mirtazapine30$343$11
Lamotrigine15$289$19
Clonazepam59$281$5
Simvastatin22$269$12
Primidone12$259$22
Verapamil Er11$240$22
Sertraline27$223$8
Nortriptyline18$199$11
Trihexyphenidyl11$177$16
Paroxetine19$155$8
Lorazepam26$135$5
Verapamil12$126$11
Omeprazole11$118$11
Fluoxetine11$47$4

Money from drug and device companies

$262 in 2025

Industry payments by year
202533None$262
202411None$124
202122None$252
202023None$161
201929None$386

Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.

A payment is not proof that care is biased.

Payments by company
CVRxBarostim Neo System$125
1 payment
  • Meals for Barostim Neo System · 2025-10-14 · $125
AstraZeneca Pharmaceuticals LPNone$122
1 payment
  • Meals · 2025-06-27 · $122
UcbRystiggo$15
1 payment
  • Education for Rystiggo · 2025-03-11 · $15
See all 3 published payments
Every published payment
CVRxMeals · 2025-10-14Barostim Neo System$125
AstraZeneca Pharmaceuticals LPMeals · 2025-06-27None$122
UcbEducation · 2025-03-11Rystiggo$15
See earlier years (2024, 2021, 2020, 2019)

2024: $124

Payments by company in 2024
Boehringer Ingelheim PharmaceuticalsNone$124
1 payment
  • Meals · 2024-06-13 · $124

2021: $252

Payments by company in 2021
Silk Road MedicalEnroute Transcarotid Neuroprotection System$129
1 payment
  • Meals for Enroute Transcarotid Neuroprotection System · 2021-08-25 · $129
GlaxoSmithKlineTrelegy Ellipta$123
1 payment
  • Meals for Trelegy Ellipta · 2021-07-15 · $123

2020: $161

Payments by company in 2020
Teva Pharmaceuticals USAAjovy$143
2 payments
  • Meals for Ajovy · 2020-03-10 · $133
  • Meals for Ajovy · 2020-01-10 · $9
Supernus PharmaceuticalsTrokendi Xr$18
1 payment
  • Meals for Trokendi Xr · 2020-03-30 · $18

2019: $386

Payments by company in 2019
Teva Pharmaceuticals USAAjovy$261
8 payments
  • Meals for Ajovy · 2019-11-25 · $7
  • Meals for Ajovy · 2019-10-31 · $7
  • Meals for Ajovy · 2019-09-30 · $9
  • Meals for Ajovy · 2019-06-20 · $13
  • Meals for Ajovy · 2019-05-22 · $10
  • Meals for Ajovy · 2019-04-26 · $103
  • Meals for Ajovy · 2019-03-21 · $15
  • Meals for Austedo · 2019-03-01 · $98
AmgenAimovig$125
1 payment
  • Meals for Aimovig · 2019-07-30 · $125

Professional record

NPI
1770560013
Licence
CA A79330California A79330: Current · expires 2028-05-31
Video visits
Lists video visits
Gender
Female
More record details
Sole proprietor
No
Taxonomy
Neurology (2084N0400X)
Mailing address
5575 W Las Positas Blvd Ste 330, Pleasanton, CA, 94588
NPI first listed
2005-12-28
NPI last updated
2023-10-05
NPI record certified
2023-10-05

This is when the NPI record was last certified, not a medical board exam.

Extra NPI addresses: 5575 W. Las Positas Blvd, Pleasanton, CA, 94588